Quiñonez-Flores, A.; Martinez-Guerra, B.A.; Román-Montes, C.M.; Tamez-Torres, K.M.; González-Lara, M.F.; Ponce-de-León, A.; Rajme-López, S.
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study. Antibiotics 2024, 13, 176.
https://doi.org/10.3390/antibiotics13020176
AMA Style
Quiñonez-Flores A, Martinez-Guerra BA, Román-Montes CM, Tamez-Torres KM, González-Lara MF, Ponce-de-León A, Rajme-López S.
Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study. Antibiotics. 2024; 13(2):176.
https://doi.org/10.3390/antibiotics13020176
Chicago/Turabian Style
Quiñonez-Flores, Alejandro, Bernardo A. Martinez-Guerra, Carla M. Román-Montes, Karla M. Tamez-Torres, María F. González-Lara, Alfredo Ponce-de-León, and Sandra Rajme-López.
2024. "Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study" Antibiotics 13, no. 2: 176.
https://doi.org/10.3390/antibiotics13020176
APA Style
Quiñonez-Flores, A., Martinez-Guerra, B. A., Román-Montes, C. M., Tamez-Torres, K. M., González-Lara, M. F., Ponce-de-León, A., & Rajme-López, S.
(2024). Cephalotin Versus Dicloxacillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteraemia: A Retrospective Cohort Study. Antibiotics, 13(2), 176.
https://doi.org/10.3390/antibiotics13020176
